glutamate
Showing 1 - 25 of 1,293
Schwannomas, Malignant Tumors Trial in Baltimore (18F-DCFPyL Injection)
Completed
- Schwannomas
- Malignant Tumors
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Jan 9, 2023
Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
Recruiting
- Brain Tumor, Primary
- Blood, CSF and tumor samples
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Mar 16, 2023
Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())
Recruiting
- Treatment Resistant Depression
- +2 more
- Ketamine Hydrochloride
- No intervention (placebo)
-
Oxford, United KingdomDepartment of Psychiatry, University of Oxford
Mar 28, 2023
Cannabis Use Disorder Trial in New Haven ([18F]FPEB with PET, Cannabis abstinence)
Not yet recruiting
- Cannabis Use Disorder
- [18F]FPEB with PET
- Cannabis abstinence
-
New Haven, ConnecticutThe Anlyan Center
Dec 22, 2022
Healthy Nutrition, Culinary Medicine, Sodium Excess Trial (MSG, NaCl (sodium chloride/table salt), KCl (potassium chloride/salt
Not yet recruiting
- Healthy Nutrition
- +2 more
- MSG
- +2 more
- (no location specified)
Oct 21, 2022
Epilepsy in Children, Epilepsy in Youth, Randomized Controlled Trial Trial in Washington (Low Glutamate diet)
Completed
- Epilepsy in Children
- +4 more
- Low Glutamate diet
-
Washington, District of ColumbiaAmerican University
Jul 18, 2022
Psychosis Trial in Albuquerque (Lumateperone, Risperidone)
Recruiting
- Psychosis
-
Albuquerque, New MexicoUniversity of New Mexico
May 25, 2023
Normal Physiology Trial run by the National Institute of Mental Health (NIMH) (3T and 7T device)
Recruiting
- Normal Physiology
- 3T and 7T device
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
MDD, Treatment Resistant Depression, Bipolar Depression Trial in Rochester (Ketamine)
Enrolling by invitation
- Major Depressive Disorder
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 12, 2022
Type1diabetes, Depressive Symptoms, MDD Trial (Glucose Clamp)
Completed
- Type1diabetes
- +2 more
- Glucose Clamp
- (no location specified)
Apr 29, 2022
Coronary Artery Bypass, Myocardial Ischemia, Myocardial Infarction Trial in Karlskrona, Linköping, Örebro (Intravenous infusion
Completed
- Coronary Artery Bypass
- +3 more
- Intravenous infusion of saline
- Intravenous glutamate infusion
-
Karlskrona, Sweden
- +2 more
May 21, 2022
Mapping Brain Glutamate in Humans: Sex Differences in Cigarette
Recruiting
- Cigarette Smoking
- +2 more
-
Los Angeles, CaliforniaUCLA Semel Institute
Mar 23, 2022
Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)
Recruiting
- Rotator Cuff Tendinitis
- Chronic Pain
- Ketalar
- NaCl 9%
-
Kristiansund, NorwayDepartment of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022
Bipolar Disorder, Cannabis Use, Schizoaffective Disorder, Bipolar Type Trial in Charleston (Gabapentin, Placebo)
Recruiting
- Bipolar Disorder
- +7 more
- Gabapentin
- Placebo
-
Charleston, South CarolinaMedical University Of South Carolina
Jul 6, 2022
Clinical High Risk for Psychosis Trial in New York (Pomaglumetad methionil)
Completed
- Clinical High Risk for Psychosis
- Pomaglumetad methionil
-
New York, New YorkNew York State Psychiatric Institute
Nov 5, 2021
Alcohol Withdrawal, Nutrition Disorders, Alcohol Use Disorder Trial (Riboflavin, Placebo)
Not yet recruiting
- Alcohol Withdrawal
- +2 more
- Riboflavin
- Placebo
- (no location specified)
Sep 27, 2021
Familial Alcoholism Vulnerability Trial in Hartford (Mavoglurant (AFQ056), Placebo)
Completed
- Familial Alcoholism Vulnerability
- Mavoglurant (AFQ056)
- Placebo
-
Hartford, ConnecticutHartford Hospital
Jan 7, 2022
Super-refractory Status Epilepticus After Cardiac Arrest
Recruiting
- Status Epilepticus
- Cardiac Arrest
- Ketamine
- Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel
-
Brescia, BS, Italy
- +6 more
Mar 1, 2023
Depressive Disorder, Treatment-Resistant Trial in London (Naltrexone, Placebo, Ketamine)
Recruiting
- Depressive Disorder, Treatment-Resistant
- Naltrexone
- +2 more
-
London, United KingdomKing's College London
Sep 28, 2021
Cocaine Dependence, Healthy Trial in New Haven (N-acetyl cysteine, [18F]FDG PET scan, 1H MRS)
Active, not recruiting
- Cocaine Dependence
- Healthy
- N-acetyl cysteine
- +3 more
-
New Haven, ConnecticutConnecticut Mental Health Center
May 20, 2022